Diagnostic accuracy
89%
Target performance vs. 67% national misdiagnosis benchmark
Premium FemTech Prototype
Menopause Intelligence Analytics
Leaders monitor safety, diagnostic velocity, and pathway quality with a premium, outcomes-first view across sites.
Time-to-diagnosis
2.5y -> 6-12m
Program objective to reduce diagnostic delays by 50%+
Patient satisfaction improvement
+34%
Pilot target across anchor provider systems
Average avoidable cost reduction
USD 1,685
Estimated waste avoided per patient from faster diagnosis
24-month ARR target
USD 8M
Health systems + payer partnership growth model
Year-4 ARR trajectory
USD 50M+
Expansion through multi-site health system and payer channels